Hour of heart failure death different for men and women

November 13, 2001

ANAHEIM, Calif., Nov. 13 - Men with fatal congestive heart failure are most likely to die at either midnight or near dawn, but women are most vulnerable just near dawn, researchers report today at the American Heart Association's Scientific Sessions 2001 conference.

"We undertook this project after we observed that many inpatient deaths due to congestive heart failure seemed to occur in the early morning," says lead author José Fabri Jr., M.D., an assistant physician at Brazil's Heart Institute (InCor), University of São Paulo Medical School. "We decided to investigate the distribution of deaths to see if they really were more frequent at certain times of the day. Gender differences were unexpected."

The mechanism behind this type of pattern may lie in the daily biological ebb and flow of hormone levels and body processes known as circadian rhythm. Circadian rhythm refers to patterns that occur on a 24-hour cycle such as sleeping, waking and hunger at certain times of the day. Earlier studies on patients who were not hospitalized have found that heart attack and sudden death tend to peak during the few hours after waking. For congestive heart failure, nighttime appears to be more risky, according to this study, which is the first to find gender differences in circadian patterns.

Fabri's group studied the deaths of 508 patients - 308 men and 200 women ages 14 to 93, average age 59 - hospitalized with terminal heart failure. They received standard treatment for their condition, which includes bed rest, diet and treatment with ACE inhibitors, diuretics and digoxin for chest pain. The researchers found that men were most likely to die near dawn, between 5 a.m. and 6:59 a.m., and also between 11 p.m. and 11:59 p.m., but women were most at risk only during the early morning hours.

"Heart failure in men is usually more severe than in women. This clinical characteristic may affect circadian patterns, and may be related to our findings," Fabri says. There is also the possibility that differences in hormonal patterns between men and women also may account for these findings, but too little is known about such differences to make any guesses, he says.

The body undergoes many cyclical changes during the day that can increase heart attack risk, Fabri says. Heart rate, blood pressure and probably even the heart's ability to contract - all determinants of oxygen demand - peak between 7 a.m. and noon. Blood levels of norepinephrine and renin activity - both of which help vessels constrict - also peak during that time.

Earlier studies have shown that congestive heart failure patients have abnormalities in their circadian patterns for blood pressure and heart rate, Fabri says. Heart rate and blood pressure generally "dip" overnight, but this is often not the case in people with heart failure.

Further studies should help clarify the mechanisms tied to these circadian patterns in heart failure death and perhaps even lead to new drugs that could modify them, he says. For instance, the Beta-Blocker Heart Attack Trial (BHAT) found that beta-blocker drugs are linked to a 44 percent reduction in the incidence of sudden cardiac death during the morning hours.

Beta blockers are not commonly used in heart failure patients; however, recent studies report that these drugs may help treat heart failure, Fabri says.

Co-authors are: Rogerio S. Depaula, M.D.; Desiderio Favarato, M.D.; Antonio C. Pereira-Barreto; M.D.; and Alfredo J. Mansur, M.D.
For information Nov. 10-14, contact Karen Hunter or Darcy Spitz at the Hilton Anaheim Hotel
(714) 251-5801

Abstract 3116 (Poster)

NR01 - 1359 (SS01/Fabri)

American Heart Association

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.